Polaris Pharmaceuticals is a global biotechnology company distinctly focused on the development of anti-cancer therapies. Part of the multinational Polaris Group, Polaris Pharmaceuticals is a full-service CDMO offering services that include fermentation, purification, process development, and fill/finish. The company operates three cGMP facilities — two in California and one in China — and has the technical expertise to guide clients from a small-scale clinical manufacturing space into commercialization for biologic drugs, performing all manufacturing processes in-house from cell bank production through fill/finish.